Pericardial fluid: an underrated molecular library of heart conditions and a potential vehicle for cardiac therapy

[1]  N. Frangogiannis.  Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. , 2019, Molecular aspects of medicine.

[2]  M. Ferrari,et al.  Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[3]  G. Angelini,et al.  Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  A. Leite-Moreira,et al.  Towards the standardization of stem cell therapy studies for ischemic heart diseases: Bridging the gap between animal models and the clinical setting. , 2017, International Journal of Cardiology.

[5]  M. Ozaydın,et al.  Relationship between site of myocardial infarction, left ventricular function and cytokine levels in patients undergoing coronary artery surgery. , 2016, Cardiovascular journal of Africa.

[6]  Hao Wang,et al.  Effects of Adenovirus-Mediated Hepatocyte Growth Factor Gene Therapy on Postinfarct Heart Function: Comparison of Single and Repeated Injections. , 2016, Human gene therapy.

[7]  M. Karabacak,et al.  Evaluation of Pericardial Fluid C-Type Natriuretic Peptide Levels in Patients Undergoing Coronary Bypass Surgery , 2016, The Thoracic and Cardiovascular Surgeon.

[8]  F. Sánchez-Margallo,et al.  Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model , 2016, PloS one.

[9]  Takeshi Kimura,et al.  Expression Patterns of miRNA-423-5p in the Serum and Pericardial Fluid in Patients Undergoing Cardiac Surgery , 2015, PloS one.

[10]  N. Al-Attar,et al.  2015 ESC Guidelines for the diagnosis and management of pericardial diseases , 2015, European heart journal.

[11]  M. Russo,et al.  Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosis. , 2015, International journal of cardiology.

[12]  Christoph H Emmerich,et al.  Optimising methods for the preservation, capture and identification of ubiquitin chains and ubiquitylated proteins by immunoblotting , 2015, Biochemical and biophysical research communications.

[13]  Z. Nemeth,et al.  Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy , 2015, PloS one.

[14]  Z. Nemeth,et al.  Pericardial fluid of cardiac patients elicits arterial constriction: role of endothelin-1. , 2015, Canadian journal of physiology and pharmacology.

[15]  F. Sánchez-Margallo,et al.  Intrapericardial Administration of Mesenchymal Stem Cells in a Large Animal Model: A Bio-Distribution Analysis , 2015, PloS one.

[16]  K. Gourgoulianis,et al.  Physiology of pericardial fluid production and drainage , 2015, Front. Physiol..

[17]  Pasi Tavi,et al.  MicroRNA Profiling of Pericardial Fluid Samples from Patients with Heart Failure , 2015, PloS one.

[18]  P. Roche,et al.  Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells , 2015, Front. Physiol..

[19]  E. Tremoli,et al.  The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases , 2014, Expert review of proteomics.

[20]  P. Ferdinandy,et al.  Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning , 2014, Pharmacological Reviews.

[21]  William Wang,et al.  Effectiveness of biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent postoperative atrial fibrillation. , 2014, The Journal of thoracic and cardiovascular surgery.

[22]  K. Dheda,et al.  Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study , 2014, BMC Medicine.

[23]  R. Fandrich,et al.  High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling , 2014, PloS one.

[24]  C. Selzman,et al.  Pharmacologic therapies for acute cardiogenic shock , 2014, Current opinion in cardiology.

[25]  G. Akpinar,et al.  Analysis of Pericardial Effusion from Idiopathic Pericarditis Patients by Two-Dimensional Gel Electrophoresis , 2014, BioMed research international.

[26]  Jelena Culej,et al.  Pleural, peritoneal and pericardial effusions – a biochemical approach , 2014, Biochemia medica.

[27]  C. Zeng,et al.  Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial , 2014, BMC Medicine.

[28]  B. Merkely,et al.  Characterization of pericardial and plasma ghrelin levels in patients with ischemic and non-ischemic heart disease , 2013, Regulatory Peptides.

[29]  Xuejiang Guo,et al.  Proteomics analysis of human pericardial fluid , 2013, Proteomics.

[30]  A. Amirzargar,et al.  Diagnostic value of interferon-gamma assay in tuberculosis pericardial effusions: study on a cohort of Iranian patients. , 2013, Acta medica Iranica.

[31]  C. Bode,et al.  Successful Therapy of Ventricular Rupture by Percutaneous Intrapericardial Instillation of Fibrin Glue: A Case Report , 2013, Case reports in vascular medicine.

[32]  A. Ristic,et al.  Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis , 2013, Heart Failure Reviews.

[33]  B. Maisch,et al.  Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion , 2013, Heart Failure Reviews.

[34]  M. Fujita,et al.  Pericardial fluid and serum biomarkers equally predict ventricular dysfunction , 2013, Asian cardiovascular & thoracic annals.

[35]  Chapter 1: Definition and classification of CKD , 2012, Kidney International Supplements.

[36]  P. Iaizzo,et al.  Cardiac Responses to the Intrapericardial Delivery of Metoprolol: Targeted Delivery Compared to Intravenous Administration , 2012, Journal of Cardiovascular Translational Research.

[37]  B. Maisch,et al.  Vascular Endothelial Growth Factor in Malignant and Benign Pericardial Effusion , 2012, Clinical cardiology.

[38]  B. Maisch,et al.  Cytokines in Pericardial Effusion of Patients with Inflammatory Pericardial Disease , 2012, Mediators of inflammation.

[39]  L. Hofbauer,et al.  Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. , 2012, Clinical biochemistry.

[40]  A. Diacon,et al.  Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis , 2011, Tuberculosis.

[41]  K. Costa,et al.  Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model , 2011, Gene Therapy.

[42]  M. Ruiz-Bailén,et al.  Administration of intrapericardial tissue adhesive after cardiac rupture and cardiac tamponade. , 2011, International journal of cardiology.

[43]  Hsien-Da Huang,et al.  microRNA: a master regulator of cellular processes for bioengineering systems. , 2010, Annual review of biomedical engineering.

[44]  Yan Zeng,et al.  Preliminary Investigation of the Clinical Value of Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor-1α in Pericardial Fluid in Diagnosing Malignant and Tuberculous Pericardial Effusion , 2010, Cardiology.

[45]  M. Capogrossi,et al.  Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. , 2010, Journal of molecular and cellular cardiology.

[46]  P. Lemos,et al.  Myocardial homing after intrapericardial infusion of bone marrow mononuclear cells. , 2009, Arquivos brasileiros de cardiologia.

[47]  J. García-Bengochea,et al.  Biochemical markers of myocardial injury in the pericardial fluid of patients undergoing heart surgery. , 2008, Interactive cardiovascular and thoracic surgery.

[48]  D. Sigg,et al.  Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. , 2008, American journal of physiology. Heart and circulatory physiology.

[49]  S. Fujiwara,et al.  Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myocardial infarction. , 2008, The American journal of cardiology.

[50]  S. Takai,et al.  Attenuating Effects of Chymase Inhibitor on Pericardial Adhesion Following Cardiac Surgery , 2007, Journal of cardiac surgery.

[51]  Le-Xin Wang,et al.  Relationship between pericardial fluid B-type natriuretic peptide and ventricular structure and function. , 2007, Archives of medical research.

[52]  H. Reuter,et al.  Diagnosing tuberculous pericarditis. , 2006, QJM : monthly journal of the Association of Physicians.

[53]  H. Ishizaka,et al.  Increased level of pericardial insulin-like growth factor-1 in patients with left ventricular dysfunction and advanced heart failure. , 2006, Journal of the American College of Cardiology.

[54]  M. Cikirikcioglu,et al.  Analysis of C-Reactive Protein and Biochemical Parameters in Pericardial Fluid , 2006, Yonsei medical journal.

[55]  L. Entz,et al.  Intrapericardial Angiotensin II Stimulates Endothelin-1 and Atrial Natriuretic Peptide Formation of the In Situ Dog Heart , 2006, Experimental biology and medicine.

[56]  K. Okumura,et al.  Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[57]  María Martín,et al.  Pericardial effusion: clinical and analytical parameters clues. , 2006, International journal of cardiology.

[58]  N. Barbetakis,et al.  Intrapericardial cisplatin administration after pericardiocentesis in patients with lung adenocarcinoma and malignant cardiac tamponade. , 2005, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[59]  R. Doughty,et al.  Intrapericardial IGF-I improves cardiac function in an ovine model of chronic heart failure. , 2005, Heart, lung & circulation.

[60]  A. Chetrit,et al.  The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. , 2005, The American journal of medicine.

[61]  K. March,et al.  Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease. , 2005, American journal of physiology. Heart and circulatory physiology.

[62]  M. Christ,et al.  Matrix metalloproteinases and their inhibitors in malignant and autoreactive pericardial effusion. , 2005, The American journal of cardiology.

[63]  L. Michalis,et al.  Intrapericardial drug delivery: pharmacologic properties and long-term safety in swine. , 2005, International journal of cardiology.

[64]  M. Kurzyna,et al.  Effectiveness of Intrapericardial Administration of Streptokinase in Purulent Pericarditis , 2004, Herz.

[65]  I. Toma,et al.  Cardiovascular Responses to Catecholamines and Interactions with Endothelin-1 and Adenine Nucleosides in the Pericardium of the Dog Heart , 2004, Journal of cardiovascular pharmacology.

[66]  I. Toma,et al.  Intrapericardial Adenine Nucleosides Induce Elevation of Endothelin-1 Concentration in the Pericardial Space of the Dog Heart , 2004, Journal of cardiovascular pharmacology.

[67]  I. Toma,et al.  Effects of Intrapericardially Administered Endothelin-1 on Pericardial Natriuretic Peptide Concentrations of the In Situ Dog Heart , 2004, Journal of cardiovascular pharmacology.

[68]  C. Cipolla,et al.  Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. , 2004, Chest.

[69]  E. Olmez,et al.  Determination of the pericardial to serum myoglobin ratio for the early diagnosis of perioperative myocardial infarction after coronary artery bypass grafting. , 2004, Pharmacological research.

[70]  S. Miyoshi,et al.  Different secretion patterns of two molecular forms of cardiac adrenomedullin in pressure- and volume-overloaded human heart failure. , 2004, Journal of cardiac failure.

[71]  J. Maessen,et al.  Intrapericardial delivery enhances cardiac effects of sotalol and atenolol. , 2004 .

[72]  D. Zipes,et al.  Intrapericardial Ibutilide Administration Fails to Terminate Pacing-Induced Sustained Atrial Fibrillation in Dogs , 2004, Cardiovascular Drugs and Therapy.

[73]  Y. Mahomed,et al.  Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease. , 2004, Journal of the American College of Cardiology.

[74]  M. Fujita,et al.  Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H-FABP) is an indicator of severe myocardial ischemia. , 2004, International journal of cardiology.

[75]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[76]  E. Duran,et al.  Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters. , 2003, Cytokine.

[77]  Kapil Kumar,et al.  Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart. , 2003, Journal of the American College of Cardiology.

[78]  F. Sellke,et al.  Intrapericardial administration of basic fibroblast growth factor: Myocardial and tissue distribution and comparison with intracoronary and intravenous administration , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[79]  Seung‐Jung Park,et al.  Comparison of polymerase chain reaction with adenosine deaminase activity in pericardial fluid for the diagnosis of tuberculous pericarditis. , 2002, The American journal of medicine.

[80]  A. Ristic,et al.  Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. , 2002, European heart journal.

[81]  F. Horkay,et al.  Pericardial concentrations of adenosine, inosine and hypoxanthine in an experimental canine model of spastic ischaemia. , 2002, Clinical science.

[82]  F. Horkay,et al.  Endothelin-1-induced elevations in purine metabolite concentrations -- autoregulatory protection in the canine pericardium? , 2002, Clinical science.

[83]  T. Misaki,et al.  Long-term usefulness of percutaneous intrapericardial fibrin-glue fixation therapy for oozing type of left ventricular free wall rupture: a case report. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[84]  N. Fineberg,et al.  Augmentation of Intrapericardial Nitric Oxide Level by a Prolonged-Release Nitric Oxide Donor Reduces Luminal Narrowing After Porcine Coronary Angioplasty , 2002, Circulation.

[85]  Rahul Mehra,et al.  Intrapericardial Therapeutics: A Pharmacodynamic and Pharmacokinetic Comparison Between Pericardial and Intravenous Procainamide Delivery , 2002, Journal of cardiovascular electrophysiology.

[86]  H. van Essen,et al.  Pharmacokinetic advantage of intrapericardially applied substances in the rat. , 2002, The Journal of pharmacology and experimental therapeutics.

[87]  M. Fujita,et al.  Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling , 2002, Heart.

[88]  J. Oyama,et al.  Elevated interleukin‐1β in pericardial fluid of patients with ischemic heart disease , 2001 .

[89]  R. Nohara,et al.  Pericardial fluid from patients with ischemic heart disease induces myocardial cell apoptotis via an oxidant stress-sensitive p38 mitogen-activated protein kinase pathway. , 2001, Journal of molecular and cellular cardiology.

[90]  Y. Kihara,et al.  Pericardial fluid as a new material for clinical heart research. , 2001, International journal of cardiology.

[91]  P. Toutouzas,et al.  Relevance of Adenosine Deaminase and Lysozyme Measurements in the Diagnosis of Tuberculous Pericarditis , 2001, Cardiology.

[92]  G. Nath,et al.  Lysozyme levels for the diagnosis of tuberculous effusions in children. , 2000, Journal of tropical pediatrics.

[93]  W. Hunter,et al.  Intrapericardial Paclitaxel Delivery Inhibits Neointimal Proliferation and Promotes Arterial Enlargement After Porcine Coronary Overstretch , 2000, Circulation.

[94]  H. Kimura,et al.  Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer , 2000, British Journal of Cancer.

[95]  D. Mouratidou,et al.  Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). , 2000, The American journal of cardiology.

[96]  Y. Kihara,et al.  Pericardial fluid from patients with ischemic heart disease accelerates the growth of human vascular smooth muscle cells. , 2000, Japanese circulation journal.

[97]  R. Nohara,et al.  Pericardial fluid from patients with unstable angina induces vascular endothelial cell apoptosis. , 2000, Journal of the American College of Cardiology.

[98]  D. Spodick.  Intrapericardial therapeutics and diagnostics. , 2000, The American journal of cardiology.

[99]  H. Yoshimoto,et al.  Oozing type cardiac rupture repaired with percutaneous injection of fibrin-glue into the pericardial space: case report. , 2000, Japanese circulation journal.

[100]  F. Horkay,et al.  Enhanced accumulation of pericardial fluid ferritin in patients with coronary artery disease , 2000, Coronary artery disease.

[101]  J. Pearlman,et al.  Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. , 2000, The Journal of pharmacology and experimental therapeutics.

[102]  E. Unger,et al.  Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. , 1999, Cardiovascular research.

[103]  P. Coriat,et al.  Pericardial cardiac troponin I release after coronary artery bypass grafting. , 1999, Anesthesia and analgesia.

[104]  A. Grothey,et al.  Treatment of malignant pericardial effusion with 32P-colloid , 1999, British Journal of Cancer.

[105]  F. Horkay,et al.  Enhanced accumulation of pericardial fluid adenosine and inosine in patients with coronary artery disease. , 1999, Life sciences.

[106]  R. Verrier,et al.  Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug delivery. , 1999, Journal of the American College of Cardiology.

[107]  Y. Kihara,et al.  Development of enzyme-linked immunosorbent assay for acidic fibroblast growth factor and its clinical application. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[108]  B. Boulanger,et al.  Pericardial fluid absorption into lymphatic vessels in sheep. , 1999, Microvascular research.

[109]  A. Saxena,et al.  Intrapericardial streptokinase in purulent pericarditis , 1999, Archives of disease in childhood.

[110]  L. Keefer,et al.  Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries: Direct comparison with endoluminal delivery , 1999, Clinical cardiology.

[111]  D. Zipes,et al.  Efficient in vivo catheter‐based pericardial gene transfer mediated by adenoviral vectors , 1999, Clinical cardiology.

[112]  A. Mebazaa,et al.  Potential paracrine role of the pericardium in the regulation of cardiac function. , 1998, Cardiovascular research.

[113]  H. Sweeney,et al.  Efficient transmural cardiac gene transfer by intrapericardial injection in neonatal mice. , 1998, Journal of molecular and cellular cardiology.

[114]  A. Goldhirsch,et al.  Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  F. Horkay,et al.  Intrapericardial infusion of endothelin-1 induces ventricular arrhythmias in dogs. , 1998, Cardiovascular research.

[116]  D. Rinkevich,et al.  Clinical Investigations: CardiologyThe Acute Effect of Minocycline on the Pericardium: Experimental and Clinical Findings , 1998 .

[117]  Y. Kihara,et al.  Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. , 1998, Journal of the American College of Cardiology.

[118]  F. Horkay,et al.  Electrophysiological Effects of Intrapericardial Infusion of Endothelin‐1 , 1998, Pacing and clinical electrophysiology : PACE.

[119]  A. Mebazaa,et al.  Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. , 1997, Circulation research.

[120]  D. Dadhania,et al.  Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. , 1997, Cardiovascular research.

[121]  S. Allen,et al.  Basic determinants of epicardial transudation. , 1997, The American journal of physiology.

[122]  Y. H. Lee,et al.  New scoring system using tumor markers in diagnosing patients with moderate pericardial effusions. , 1997, International journal of cardiology.

[123]  F. Horkay,et al.  Characterization and stimuli for production of pericardial fluid atrial natriuretic peptide in dogs. , 1997, Life sciences.

[124]  W. Tomkowski,et al.  Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. , 1997, Lung cancer.

[125]  M. Aoki,et al.  Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method. , 1997, Journal of molecular and cellular cardiology.

[126]  R. Nohara,et al.  Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. , 1996, Circulation.

[127]  D. Zipes,et al.  Amiodarone Instilled Into the Canine Pericardial Sac Migrates Transmurally to Produce Electrophysiologic Effects and Suppress Atrial Fibrillation , 1996, Journal of cardiovascular electrophysiology.

[128]  W. Markiewicz,et al.  Intrapericardial minocycline sclerosis for malignant pericardial effusion. , 1996, Chest.

[129]  Y. Uchida,et al.  Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. , 1995, American heart journal.

[130]  S. Komşuoğlu,et al.  The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis. , 1995, European heart journal.

[131]  A. Jacobs,et al.  Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. , 1995, American heart journal.

[132]  A. G. Driver,et al.  Pericardial fluid adenosine in ischemic and valvular heart disease. , 1995, Chest.

[133]  K. Koh,et al.  Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. , 1994, Circulation.

[134]  M. Shichiri,et al.  Atrial natriuretic peptide in the pericardial fluid of patients with heart disease. , 1993, Clinical science.

[135]  K. Cho,et al.  Extracellular fluid translocation in perfused rabbit atria: implication in control of atrial natriuretic peptide secretion. , 1993, The Journal of physiology.

[136]  G. Goings,et al.  Permeability of rat atrial endocardium, epicardium, and myocardium to large molecules. Stretch-dependent effects. , 1992, Circulation research.

[137]  Y. Otsuki,et al.  Lymphatics and pre-lymphatics of the rabbit pericardium and epicardium with special emphasis on particulate absorption and milky spot-like structures. , 1991, Lymphology.

[138]  S. Nakagawa,et al.  Intrapericardial ok‐432 instillation for the management of malignant pericardial effusion , 1991, Cancer.

[139]  D. Zipes,et al.  Pericardial prostaglandin biosynthesis prevents the increased incidence of reperfusion-induced ventricular fibrillation produced by efferent sympathetic stimulation in dogs. , 1990, Circulation.

[140]  A. Honda,et al.  Insulin-like growth factor I (IGF-I) enhances hyaluronic acid synthesis in rabbit pericardium. , 1989, Biochimica et biophysica acta.

[141]  D. Zipes,et al.  Modulation of Cardiac Autonomic Neurotransmission by Epicardial Superfusion Effects of Hexamethonium and Tetrodotoxin , 1989, Circulation research.

[142]  M. Pelegrí,et al.  Adenosine deaminase in body fluids: a useful diagnostic tool in tuberculosis. , 1989, Clinical biochemistry.

[143]  A. Paccagnella,et al.  Intrapericardial instillation of platin in malignant pericardial effusion , 1988, Cancer.

[144]  F. Shepherd,et al.  Medical management of malignant pericardial effusion by tetracycline sclerosis. , 1987, The American journal of cardiology.

[145]  A. Honda,et al.  Hyaluronic acid in rabbit pericardial fluid and its production by pericardium , 1986, FEBS letters.

[146]  S. Stewart,et al.  Antibody-guided irradiation of malignant pleural and pericardial effusions. , 1986, British Journal of Cancer.

[147]  G. Dusting,et al.  Pericardial Release of Prostacyclin Induced by Bradykinin and Angiotensin II: Effects on Coronary Blood Flow in the Dog , 1983, Journal of cardiovascular pharmacology.

[148]  T. Martin,et al.  Prostacyclin produced by the pericardium and its influence on coronary vascular tone. , 1983, The American journal of cardiology.

[149]  R Rubio,et al.  Consistent Parallel Relationships among Myocardial Oxygen Consumption, Coronary Blood Flow, and Pericardial Infusate Adenosine Concentration with Various Interventions and β‐Blockade in the Dog , 1983, Circulation research.

[150]  T. Martin,et al.  The pericardium as a source of prostacyclin in the dog, ox and rat. , 1982, Prostaglandins.

[151]  G. Dusting,et al.  STIMULATION OF PROSTACYCLIN RELEASE FROM THE EPICARDIUM OF ANAESTHETIZED DOGS , 1981, British journal of pharmacology.

[152]  M. Segal,et al.  A study of the routes by which protein passes from the pericardial cavity to the blood in rabbits. , 1978, The Journal of physiology.

[153]  M. Segal,et al.  A study of the composition of pericardial fluid, with special reference to the probable mechanism of fluid formation. , 1978, The Journal of physiology.

[154]  H. Uhley,et al.  Lymphatic pathways and rate of absorption of 131I-albumin from pericardium of dogs. , 1977, Lymphology.

[155]  R. Mellins,et al.  Effect of systemic and pulmonary venous hypertension on pleural and pericardial fluid accumulation , 1970 .

[156]  D. Spodick.  Medical history of the pericardium. The hairy hearts of hoary heroes. , 1970, The American journal of cardiology.

[157]  C. K. Drinker,et al.  THE COMPOSITION OF MAMMALIAN PERICARDIAL AND PERITONEAL FLUIDS , 1940 .

[158]  J. Deitrick,et al.  Absorption from the pericardial cavity in man , 1938 .

[159]  C. K. Drinker,et al.  ABSORPTION FROM THE PERICARDIAL CAVITY , 1931, The Journal of experimental medicine.

[160]  C. Asher,et al.  Pericarditis , 1830, The Medico-chirurgical review.

[161]  B. Hoit.  Pathophysiology of the Pericardium. , 2017, Progress in cardiovascular diseases.

[162]  W. Saliba,et al.  Interventional Pericardiology , 2016, Current Cardiology Reports.

[163]  O. Mehmet,et al.  Relationship between site of myocardial infarction, left ventricular function and cytokine levels in patients undergoing coronary artery surgery , 2016, Cardiovascular Journal of Africa.

[164]  J. Bourque,et al.  Coronary Microvascular Dysfunction, Microvascular Angina, and Management , 2015, Current Cardiology Reports.

[165]  J. Hung,et al.  Pericardial diseases. , 2012, Current problems in cardiology.

[166]  K. Shyu,et al.  Pericardial fluid and serum levels of vascular endothelial growth factor and endostatin in patients with or without coronary artery disease. , 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.

[167]  A. Fijałkowska,et al.  Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion , 2005, Journal of Cancer Research and Clinical Oncology.

[168]  A. Fijałkowska,et al.  Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade , 2004, Supportive Care in Cancer.

[169]  Y. Kihara,et al.  Elevation of matrix metalloproteinase-2 level in pericardial fluid is closely associated with left ventricular remodeling. , 2002, The American journal of cardiology.

[170]  M. Kılınç,et al.  Intrapericardial fibrinolytic therapy in purulent pericarditis. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[171]  R. Nohara,et al.  Myocardial ischemia enhances the expression of acidic fibroblast growth factor in human pericardial fluid , 2000, Heart and Vessels.

[172]  J. C. G. Rubira,et al.  Cisplatino intrapericárdico en el taponamiento neoplásico , 2000 .

[173]  F. Horkay,et al.  Potential pathophysiologic role of endothelin-1 in canine pericardial fluid. , 1998, Journal of cardiovascular pharmacology.

[174]  F. Horkay,et al.  High pericardial fluid levels of endothelin are not caused by altered neutral endopeptidase activity in cardiac patients. , 1998, Journal of cardiovascular pharmacology.

[175]  B. Davidson,et al.  Intrapericardial administration of adenovirus for gene transfer. , 1997, The American journal of physiology.

[176]  J. Willerson,et al.  Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries. , 1996, Texas Heart Institute journal.

[177]  N. Viñolas,et al.  Intracavitary oxytetracycline in malignant pericardial tamponade. , 1992, Oncology.

[178]  G. Koh,et al.  Presence of immunoreactive atrial natriuretic peptides in pericardial fluid of human subjects with congenital heart diseases. , 1990, Life sciences.

[179]  D. Zipes,et al.  Prostaglandins in the pericardial fluid modulate neural regulation of cardiac electrophysiological properties. , 1990, Circulation research.

[180]  K. Nokihara,et al.  The heart is the center of a new endocrine, paracrine, and neuroendocrine system. , 1989, Archives of histology and cytology.

[181]  H. Iishi,et al.  Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis. , 1984, Oncology.

[182]  G. Szabó,et al.  Protein absorption from the perricardial cavity , 1975, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[183]  H. Nino,et al.  Electrolyte and acid-base composition of pericardial fluid in man. , 1971, Archives of surgery.

[184]  L. Wolff,et al.  DISEASES OF THE PERICARDIUM. , 1965, Annual review of medicine.

[185]  W. Geinitz,et al.  Über die eiweisse der perikardialflüssigkeit des menschen , 1958 .